Navigation Links
Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
Date:6/8/2009

On June 8, 2009, Oxygen Biotherapeutics commenced a limited offering to approximately 77 persons who hold 120,431,920 of our common stock purchase warrants to exchange the warrants for cash and restricted common stock of Oxygen Biotherapeutics. There is no minimum total number of warrants that must be offered for exchange to Oxygen Biotherapeutics by the holders. All offers for exchange must be delivered to Oxygen Biotherapeutics on or before July 9, 2009. Oxygen Biotherapeutics does not expect that it will accept for exchange more than approximately 80 million warrants due to budgetary constraints. Nevertheless, we reserve the right to accept and exchange all warrants offered, even if more than 80 million. For all but 2.7 million of the warrants we are offering to exchange for each warrant $0.04 in cash and one-half (1/2) share of restricted common stock. For the remaining 2.7 million warrants we are offering to exchange for each warrant $0.001 in cash and one-quarter (1/4) share of restricted common stock.

Caution Regarding Forward-Looking Statements

This news release contains certain forward-looking statements by Oxygen Biotherapeutics, Inc. that involve risks and uncertainties and reflect the company's judgment as of the date of this release. These statements include those referring to plans to buy back outstanding warrants and milestones for future investment by Vatea Fund. Actual events or results may differ from Oxygen Biotherapeutics's expectations. There can be no assurance that holders of outstanding warrants will agree to sell them to the company on the terms offered or that the company will achieve the milestones required to receive additional funds from Vatea Fund. Additional information concerning these and other risk factors affecting Oxygen Biotherapeutics's business can be found in the company's public report filings with the Securities and Exchange Commission, which are available on the SEC website at '/>"/>

SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Oxygen + MRI might help determine cancer therapy success, researchers find
2. Hummingbird Coaching Partners with Leeza's Place to Help Caregivers “Take Your Oxygen First”
3. Long-term study shows low oxygen levels in prostate tumors can predict recurrence
4. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
5. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
6. Turtle Island Oxygen Trust Sponsors Free Hyperbaric Treatments
7. G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab
8. Octi-Flo2™ - 8 Patient Portable Oxygen Delivery System
9. House Republican Leader Boehner Says CMS Policies on Home Oxygen Therapy Will Potentially Harm Care Available to Medicare Beneficiaries
10. Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
11. Ozone/Oxygen Shot Helps Heal Herniated Disk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... It's not astonishing that holidays are amongst ... are endless, from family, friends and co-workers. Between the ... more than their parents can afford, parties to arrange, ... graduations, birthdays, anniversaries and it seems like an eternal ... become tired and income can’t catch up to the ...
(Date:5/25/2013)... May 25, 2013 Communities of Distinction ... It is the fifth largest media market in the United ... number one visitor destination in Texas and a major convention ... the American West as it is home to many major ... enjoy from sports to the arts. Residents and locals will ...
(Date:5/25/2013)... -- Animals make great companions for senior citizens, but elderly ... are far more likely to crash than those who never ... study included 2,000 licensed drivers aged 70 and older. The ... they drove with their pet in the car. Among ... was twice as high as among those who never drove ...
(Date:5/25/2013)... St Louis, MO (PRWEB) May 25, 2013 ... goal for the Diet Doc team of weight management professionals. ... weight fast and effectively, Diet Doc’s hCG diets ... uncontrollable factors like abuse during childhood like bullying, more control ... not directly capable of dealing with the underlying factors of ...
(Date:5/25/2013)... May 25, 2013 The latest ... from irritable bowel syndrome (IBS) to bloating, constipation, ... the most long-lasting, embarrassing, frustrating and difficult health ... for digestive health have provided a cure ... many factors contributing to digestive health issues, a ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2
... initiation of lifesaving antiretroviral therapies should be the standard of ... limited medical and financial resources, according to a study led ... Tutu HIV Centre, University of Cape Town, South Africa. ... Internal Medicine that starting antiretroviral therapy (ART) when the ...
... , LOS ANGELES, July 20 Dr. Chugay, a leading ... patch procedure to aid patients with goals of rapid weight loss. , ... over thir ty years of experience and has personally performed ... surgery expert on The Tonight Show , Entertainment Weekly , CNN ...
... , FLEMINGTON, N.J., July 20 A new national ... (82%) do not believe that drugs containing acetaminophen should be pulled ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071204/NYTU133LOGO ) , , ... during July 17-19, to obtain physicians, perceptions of a CNN news ...
... , , NEW YORK, ... controversial and thought provoking topics today, MTV,s "16 & Pregnant" season ... (2.1 million) on Thursday, July 16, ranking as the number one ... their favorite series with the "16 & Pregnant: Life After Labor" ...
... working on H1N1 swine flu vaccine, which should be ready ... U.S. Food and Drug Administration has approved the vaccine to ... , The agency noted that this vaccine will not protect ... pandemic proportions around the world and is expected to return ...
... , GREENFIELD, Wis., July 20 ... nutritional service and meal-planning program for cancer patients. The web-based ... . Founded by cancer survivors, the program is based ... It is available to cancer patients and health care systems ...
Cached Medicine News:Health News:Earlier HIV antiviral treatment can be cost effective in areas of limited resources 2Health News:Dr. Chugay (drchugay.com) - Revolutionary Weight Loss Surgery 2Health News:Docs Say No to Pulling Drugs Containing Acetaminophen off the Market 2Health News:Docs Say No to Pulling Drugs Containing Acetaminophen off the Market 3Health News:MTV's Season Finale of '16 & Pregnant' Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program 2Health News:MTV's Season Finale of '16 & Pregnant' Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program 3Health News:MTV's Season Finale of '16 & Pregnant' Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program 4Health News:MTV's Season Finale of '16 & Pregnant' Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program 5Health News:FDA Approves Seasonal Flu Vaccine for 2009-2010 2Health News:FDA Approves Seasonal Flu Vaccine for 2009-2010 3Health News:Cancer Survivors Launch New Company, TherapEase Cuisine 2
(Date:5/24/2013)... , May 24, 2013  BD (Becton, Dickinson and ... technology company, announced today that it will present at the ... Thursday, May 30, 2013, at 10:40 a.m. (ET). ... from the BD corporate website at www.bd.com/investors and ... About BD BD is a ...
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
(Date:5/24/2013)... England and BOSTON , May 24, ... discovery and development company, is pleased to announce that it has ... to augment the Company,s business development capabilities in Japan ... more than 15 years of experience in business development, licensing and ... Sciences, Inc., Roche Pharma ( Japan ), Nippon Roche ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Scientist to Present Results at 2007 American ... 09, 2007 /PRNewswire-FirstCall/ -- Cleveland,BioLabs, Inc. , ... of,Protectan CBLB502's efficacy as a mitigator of ... damage in non-human primates. The,Company's Chief Scientific ...
... Pa.--(BUSINESS WIRE)--Apr 9, 2007 -,GlaxoSmithKline (LSE and ... from Study 767905/014 and,provided an update on ... 014, a Phase 3, double blind, placebo-controlled ... long-term safety and,tolerability of alvimopan 0.5 mg ...
Cached Medicine Technology:Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 2Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7
Anterior chamber protein cell meter. Laser flare meter and cell-counting functions are included in this cell meter, with dramatically enhanced measurement of cell volume....
... new SureSigns VS1 is an ... monitor that provides reliable, accurate, ... VS1 is designed to make ... like large, bright, color-coded LED ...
... High-performance monitoring at the patients side and ... monitors provide essential measurements in a compact ... needs of post-operative care, lower acuity environments, ... strong heritage in patient monitoring, the IntelliVue ...
... Built on Philips strong heritage in ... configuration; an extensive clinical measurements menu; built-in ... EASI* derived 12-lead ECG, and arrhythmia analysis; ... is easy to use and operates on ...
Medicine Products: